BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Business

  Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update

  Vaxcyte, Inc., a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced financial results for the first quarter ended March 31, 2024, and provided a business update.

  May 8, 2024

   · 

  13 min read
• Business

  Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update

  Olema Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.

  May 8, 2024

   · 

  11 min read
• Business

  Terns Pharmaceuticals Announces Leadership Changes

  Terns Pharmaceuticals, Inc. announced the appointment of Scott Harris as chief development officer effective May 28, 2024 and the upcoming departure of Erin Quirk, M.D., president, head of research and development.

  May 8, 2024

   · 

  6 min read
• Business

  CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

  CRISPR Therapeutics, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, reported financial results for the first quarter ended March 31, 2024.

  May 8, 2024

   · 

  17 min read
• Business

  Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

  Relmada Therapeutics, Inc., a late-stage biotechnology company addressing diseases of the central nervous system, provided a corporate update and announced preliminary and unaudited financial results for the first quarter ended March 31, 2024.

  May 8, 2024

   · 

  10 min read
• Business

  Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management

  Biodesix, Inc., a leading diagnostic solutions company with a focus in lung disease, announced its financial and operating results for the first quarter ended March 31, 2024, and provided a corporate update.

  May 8, 2024

   · 

  14 min read
• Business

  ChromaDex Corporation Reports First Quarter 2024 Financial Results

  ChromaDex Corp. announced financial results for the first quarter of 2024.

  May 8, 2024

   · 

  13 min read
• Bio NC

  Dentsply Sirona to Participate in Upcoming May 2024 Investor Conferences

  DENTSPLY SIRONA Inc. announced its participation at upcoming conferences.

  May 8, 2024

   · 

  1 min read
• Oculis Reports Q1 2024 Financial Results and Provides Company Updates

  Oculis Holding AG, a global biopharmaceutical company purposefully driven to save sight and improve eye care, announced results for the three-month period ended March 31, 2024, and an overview of the Company’s progress.

  May 8, 2024

   · 

  12 min read
• Business

  Outset Medical Reports First Quarter 2024 Financial Results

  Outset Medical, Inc., a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, reported financial results for the first quarter ended March 31, 2024.

  May 8, 2024

   · 

  14 min read